FI972542A0 - Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten - Google Patents

Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten

Info

Publication number
FI972542A0
FI972542A0 FI972542A FI972542A FI972542A0 FI 972542 A0 FI972542 A0 FI 972542A0 FI 972542 A FI972542 A FI 972542A FI 972542 A FI972542 A FI 972542A FI 972542 A0 FI972542 A0 FI 972542A0
Authority
FI
Finland
Prior art keywords
amount
pct
therapeutic dose
effective therapeutic
active agents
Prior art date
Application number
FI972542A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972542A (fi
Inventor
Bruno Bevan
Cecile Aillaud
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of FI972542A publication Critical patent/FI972542A/fi
Publication of FI972542A0 publication Critical patent/FI972542A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI972542A 1994-12-21 1997-06-16 Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten FI972542A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415416A FR2728463A1 (fr) 1994-12-21 1994-12-21 Systeme transdermique d'administration simultanee de plusieurs principes actifs
PCT/FR1995/001696 WO1996019203A1 (fr) 1994-12-21 1995-12-19 Systeme transdermique d'administration simultanee de plusieurs principes actifs

Publications (2)

Publication Number Publication Date
FI972542A FI972542A (fi) 1997-06-16
FI972542A0 true FI972542A0 (fi) 1997-06-16

Family

ID=9470067

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972542A FI972542A0 (fi) 1994-12-21 1997-06-16 Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten

Country Status (24)

Country Link
US (1) US5919477A (xx)
EP (1) EP0800386B1 (xx)
JP (1) JPH10510823A (xx)
KR (1) KR980700071A (xx)
CN (1) CN1072929C (xx)
AT (1) ATE173164T1 (xx)
AU (1) AU692042B2 (xx)
CA (1) CA2208374A1 (xx)
CZ (1) CZ183297A3 (xx)
DE (1) DE69506007T2 (xx)
DK (1) DK0800386T3 (xx)
ES (1) ES2125679T3 (xx)
FI (1) FI972542A0 (xx)
FR (1) FR2728463A1 (xx)
HK (1) HK1004375A1 (xx)
HU (1) HUT77384A (xx)
NO (1) NO972467L (xx)
NZ (1) NZ298826A (xx)
PL (1) PL182452B1 (xx)
RU (1) RU2157193C2 (xx)
SI (1) SI0800386T1 (xx)
SK (1) SK280631B6 (xx)
UA (1) UA42806C2 (xx)
WO (1) WO1996019203A1 (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
DE69926017T2 (de) 1998-04-27 2005-12-22 SurModics, Inc., Eden Prairie Bioaktive Wirkstoffe freisetzende Beschichtungen
DE10025970C2 (de) * 2000-05-25 2002-04-25 Lohmann Therapie Syst Lts Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US7243788B2 (en) * 2003-10-22 2007-07-17 Kimberly-Clark Worldwide, Inc. Package for segregating and mixing substances
GEP20084561B (en) * 2003-10-28 2008-12-10 Noven Pharma System and method for controlled drug release and transdermal drug delivery device
US20050244459A1 (en) * 2004-04-06 2005-11-03 Dewitt David M Coating compositions for bioactive agents
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
US20090202609A1 (en) * 2008-01-06 2009-08-13 Keough Steven J Medical device with coating composition
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014062839A1 (en) 2012-10-16 2014-04-24 Surmodics, Inc. Wound packing device and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE3903794A1 (de) * 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator

Also Published As

Publication number Publication date
US5919477A (en) 1999-07-06
ES2125679T3 (es) 1999-03-01
SK280631B6 (sk) 2000-05-16
UA42806C2 (uk) 2001-11-15
SI0800386T1 (en) 1999-04-30
HUT77384A (hu) 1998-04-28
FR2728463A1 (fr) 1996-06-28
NZ298826A (en) 1998-10-28
NO972467D0 (no) 1997-05-30
FI972542A (fi) 1997-06-16
JPH10510823A (ja) 1998-10-20
CA2208374A1 (en) 1996-06-27
AU4450596A (en) 1996-07-10
RU2157193C2 (ru) 2000-10-10
MX9704527A (es) 1997-10-31
ATE173164T1 (de) 1998-11-15
CZ183297A3 (en) 1997-10-15
AU692042B2 (en) 1998-05-28
CN1170359A (zh) 1998-01-14
EP0800386B1 (fr) 1998-11-11
DK0800386T3 (da) 1999-07-26
NO972467L (no) 1997-06-17
KR980700071A (ko) 1998-03-30
DE69506007D1 (de) 1998-12-17
PL320883A1 (en) 1997-11-10
CN1072929C (zh) 2001-10-17
FR2728463B1 (xx) 1997-02-21
HK1004375A1 (en) 1998-11-27
PL182452B1 (pl) 2002-01-31
SK79197A3 (en) 1997-12-10
DE69506007T2 (de) 1999-06-10
WO1996019203A1 (fr) 1996-06-27
EP0800386A1 (fr) 1997-10-15

Similar Documents

Publication Publication Date Title
FI972542A0 (fi) Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
NO20064395L (no) Anvendelse av buprenorfin i fremstilling av et medikament
DK0586621T3 (da) Linsidomin til behandling af erektile dysfunktioner
BG103552A (en) Therapeutical forms
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
ATE190225T1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
ATE322272T1 (de) Neue formulierungen zur transdermale verabreichung von fluoxetin
ATE295157T1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
PL348202A1 (en) Pharmaceutically active composition and dispensing device
YU71293A (sh) Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu
DE69814669T2 (de) Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten